Dynacure has secured orphan drug designation from the US Food and Drug Administration (FDA) for investigational antisense medicine DYN101, which has been designed to modulate the expression of dynamin 2...
9 August 2019 News
6 August 2019 News
Sanofi has announced positive top-line, Phase III results for Dupixent (dupilumab) in children aged six to 11 years old with atopic dermatitis.
6 August 2019 Analysis
This has been a landmark year for HIV treatment; a seven-year study confirmed that taking ART can prevent transmission between gay couples and a second patient has been effectively cured...
1 August 2019 Comment
With a highly effective experimental vaccine to hand, why is Ebola containment proving so difficult?
Given V920’s striking efficacy in preventing Ebola infection and subsequent associated morbidity and mortality, it would stand to reason that Ebola is no longer the threat it was once and...
30 July 2019 News
ViiV Healthcare and Janssen Pharmaceutical have filed separate marketing authorisation applications (MAA) for the use of their respective drugs, cabotegravir and rilpivirine, as a combination therapy in adults with HIV...
26 July 2019 Analysis
One of the forms of viral hepatitis the world wants to eliminate by 2030 is hepatitis B. But while it is possible to prevent transmission and supress the virus, researchers...
25 July 2019 News
French biotech firm Valneva has received a grant of up to $23.4m from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a single-dose, live-attenuated Chikungunya vaccine.
24 July 2019 Comment
The only way we can combat the effects of malaria is by making sure funding is adequate, health education is continued and awareness of the problem is made clear to...
24 July 2019 News
Johnson & Johnson (J&J) has formed an international research consortium to focus on the discovery and development of new antibiotics to treat tuberculosis (TB).